Morristown, N.J. and Mumbai, India, Sept 13, 2021—OmniActive Health Technologies (OmniActive) announced today the appointment of Adam Adelmann as its Chief Commercial Officer. Adam will be based in OmniActive’s Morristown, USA office.
“Adam brings a wealth of experience to this position, and I believe he will enable our organization to reach greater heights,” said Mark Dewis, CEO of OmniActive.
Adam is a seasoned sales leader with nearly two decades of B2B / industry experience. He has worked in leadership positions at companies such as Lonza, Capsugel, Air Products and Pfizer. Adam has extensive expertise in business development, strategic growth planning and driving innovation while building and leading high-performing teams. Adam is a science graduate from West Chester University of Pennsylvania and has studied at the Wharton School at the University of Pennsylvania.
“I am thrilled to join OmniActive as its Chief Commercial Officer and I look forward to contributing to its growth journey,” said Adam. “Their reputation as a quality, science-based company is unparalleled, which is the key to success in this market.”
Established in 2005, OmniActive seeks to improve lives through innovative science and natural health solutions. OmniActive’s product portfolio consists of scientifically validated, IP-protected, branded Specialty Actives and an extensive line of natural Botanical Actives for global customers in the dietary supplement, functional food, and beverage markets.
The Company’s leading brands include Lutemax 2020, Lutemax Free Lutein and Lutein Esters, Capsimax, Curcuwin, Gingever, Xtenergy, Nutritears and Omnixan. OmniActive partners with customers through its sales and distribution networks in key markets worldwide, supported by three global R&D centers and best-in-class production facilities throughout India. The Company has offices in Mumbai, India and Morristown, New Jersey.